Small molecule ligands define a binding site on the immune regulatory protein B7.1 (Q56904575)

1

0 references

Suyue Wang

2

0 references

Yuzhe Xing

3

0 references

James F Tobin

Journal of Biological Chemistry

4

0 references

language of work or name

English

0 references

publication date

1 March 2002

0 references

published in

0 references

volume

277

0 references

issue

9

0 references

page(s)

7363-8

0 references

cites work

CD28/B7 costimulation: a review

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Shape complementarity at protein/protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Cytoskeletal polarization and redistribution of cell-surface molecules during T cell antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Molecular basis of T cell inactivation by CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Site-directed ligand discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Structure and dimerization of a soluble form of B7-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Discovering high-affinity ligands for proteins: SAR by NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

A hot spot of binding energy in a hormone-receptor interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

The maximal affinity of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Analysis of the binding surfaces of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Functionality maps of binding sites: a multiple copy simultaneous search method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Multiple activation states of integrin alpha4beta1 detected through their different affinities for a small molecule ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200

Identification and structural determination of a potent P-selectin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M110162200